bay-k-8644 has been researched along with thromboxane a2 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faber, JE; Meininger, GA | 1 |
| Dunlop, PC; From, AH; Johnson, GJ; Leis, LA | 1 |
| Fujiwara, M; Kurahashi, K; Manabe, K; Shirahase, H; Usui, H | 1 |
| Antunes, E; De Nucci, G; Muscará, MN; Ribeiro, MO; Zatz, R | 1 |
| Walker, BR | 1 |
| Champion, HC; Kadowitz, PJ | 1 |
6 other study(ies) available for bay-k-8644 and thromboxane a2
| Article | Year |
|---|---|
Selective interaction of alpha-adrenoceptors with myogenic regulation of microvascular smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Microcirculation; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Thromboxane A2; Vasoconstriction | 1990 |
Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Humans; In Vitro Techniques; Ion Channels; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandins H; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane A2; Thromboxanes | 1988 |
An endothelium-dependent contraction induced by A-23187, a Ca++ ionophore in canine basilar artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aspirin; Basilar Artery; Calcimycin; Dogs; Endothelium, Vascular; Female; Male; Methacrylates; Nifedipine; Quinacrine; Thromboxane A2; Vasoconstriction | 1988 |
Nifedipine prevents renal injury in rats with chronic nitric oxide inhibition.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arginine; Blood Pressure; Calcium Channel Blockers; Hemodynamics; Hypertension; In Vitro Techniques; Kidney; Kidney Glomerulus; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Thromboxane A2; Time Factors; Vasoconstrictor Agents | 1995 |
Evidence for uneven distribution of L-type calcium channels in rat pulmonary circulation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Vessels; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Male; Nifedipine; Potassium; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Thromboxane A2; Tissue Distribution; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Albuterol; Alprostadil; Analysis of Variance; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Bradykinin; Cats; Cromakalim; Endothelium, Vascular; Female; Glyburide; Heart Rate; Hindlimb; Hydrazines; Isradipine; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitrogen Oxides; Nitroprusside; Norepinephrine; Penicillamine; Prostaglandin Endoperoxides, Synthetic; Pyrroles; S-Nitroso-N-Acetylpenicillamine; Substance P; Tetraethylammonium; Tetraethylammonium Compounds; Thromboxane A2; Vasoactive Intestinal Peptide; Vasodilation; Vasodilator Agents | 1997 |